Company Information
USD
5.62
- (-4.6%)
NASDAQ:EDIT, EDITAS MEDICINE, INC.
Industry: Biotechnology
End of Day: 17 May 2024 GMT-4
Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR)/ CRISPR-associated protein 9 (Cas9 technology). It has developed CRISPR/Cas9 technology which uses a protein-RNA (ribonucleic acid) complex composed of the Cas9 enzyme bound to a guide RNA molecule designed to recognize a DNA (deoxyribonucleic acid) sequence that requires repair. The company is engaged in developing and commercializing genome editing technology.
Address
11 Hurley Street
Classification
Sector
Healthcare
Industry Group
Biotechnology
Industry
Biotechnology
Key Executives
Dr. Akshay K. Vaishnaw, M.D.,PhD
Director
Mr. Andrew J. Hirsch
Director
Dr. Mark S. Shearman
Executive VP
Dr. Jessica Hopfield, PhD
Director
Ms. Emma Reeve
Chairman of the Board/Director
Mr. Erick J. Lucera, C.F.A.
CFO/Chief Accounting Officer/Executive VP
Dr. David T. Scadden, M.D.
Director
Ms. Bernadette M. Connaughton
Director
Dr. Gilmore O’Neill, M.B.
CEO/Director/President
Dr. Meeta Chatterjee, PhD
Director
Dr. Elliott M. Levy, M.D.
Director
Mr. Baisong Mei, M.D.,PhD
Chief Medical Officer/Senior VP
Ownership
Institution Holdings
Vanguard Group Inc
8,461,857 (10.361%)
BlackRock Inc
7,838,969 (9.598%)
Deep Track Capital, LP
5,473,086 (6.701%)
State Street Corporation
5,069,543 (6.207%)
BlackRock Fund Advisors
3,706,752 (4.538%)
SSGA Funds Management Inc
3,456,125 (4.232%)
Vanguard Investments Australia Ltd
2,610,193 (3.196%)
Dimensional Fund Advisors, Inc.
2,392,396 (2.929%)
Pictet Asset Manangement SA
1,981,679 (2.426%)
Geode Capital Management, LLC
1,901,735 (2.328%)
Funds Holdings
SPDR® S&P Biotech ETF
3,345,727 (4.096%)
Vanguard Small Cap Index
2,085,652 (2.554%)
iShares Russell 2000 ETF
1,991,124 (2.438%)
Vanguard Institutional Extnd Mkt Idx Tr
1,269,659 (1.555%)
Vanguard Small Cap Growth Index Fund
1,161,952 (1.423%)
JPM Thematics Genetic Therapies
916,062 (1.122%)
Fidelity Small Cap Index Fund
820,101 (1.004%)
iShares Russell 2000 Value ETF
767,134 (0.939%)
iShares Biotechnology ETF
618,349 (0.757%)
Fidelity Extended Market Index Fund
455,638 (0.558%)
Make Smart Investment Choices